drugset / Trial / NCT02813863

The Drug-drug Interaction of SP2086 and Metformin

NCT02813863

Phase 1 Completed 24 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This is an open single and self-control study,planning to recruit 24 cases of healthy male volunteers.In the study,subjects were given SP2086 and metformin,and collects blood samples before and after medcine.The purpose is to evaluate the drug interaction between SP2086 and Metformin.

Timeline

Start
2015-12
Primary completion
2016-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg
Subject Retagliptin Small molecule 100 mg